Bmf-500: An Orally Bioavailable Covalent Inhibitor of FLT3 with High Selectivity and Potent Antileukemic Activity in FLT3-Mutated AML

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 6191 - 6192
Main Authors Law, Brian, Rughwani, Tripta, Archer, Tenley C., Kumar, Lekha, Lu, Daniel, Somanath, Priyanka, Ma, Yan, Wang, Xiaodong, Sperandio, David, Morris, Steve, Kirschberg, Thorsten, Balakrishnan, Mini, Butler, Thomas
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

Author Somanath, Priyanka
Kirschberg, Thorsten
Balakrishnan, Mini
Wang, Xiaodong
Butler, Thomas
Archer, Tenley C.
Rughwani, Tripta
Kumar, Lekha
Sperandio, David
Morris, Steve
Law, Brian
Lu, Daniel
Ma, Yan
Author_xml – sequence: 1
  givenname: Brian
  surname: Law
  fullname: Law, Brian
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 2
  givenname: Tripta
  surname: Rughwani
  fullname: Rughwani, Tripta
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 3
  givenname: Tenley C.
  surname: Archer
  fullname: Archer, Tenley C.
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 4
  givenname: Lekha
  surname: Kumar
  fullname: Kumar, Lekha
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 5
  givenname: Daniel
  surname: Lu
  fullname: Lu, Daniel
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 6
  givenname: Priyanka
  surname: Somanath
  fullname: Somanath, Priyanka
  organization: Biomea Fusion Inc., Redwood City, CA
– sequence: 7
  givenname: Yan
  surname: Ma
  fullname: Ma, Yan
  organization: Biomea Fusion Inc., Redwood City, CA
– sequence: 8
  givenname: Xiaodong
  surname: Wang
  fullname: Wang, Xiaodong
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 9
  givenname: David
  surname: Sperandio
  fullname: Sperandio, David
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 10
  givenname: Steve
  surname: Morris
  fullname: Morris, Steve
  organization: Biomea Fusion Inc., Redwood City, CA
– sequence: 11
  givenname: Thorsten
  surname: Kirschberg
  fullname: Kirschberg, Thorsten
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 12
  givenname: Mini
  surname: Balakrishnan
  fullname: Balakrishnan, Mini
  organization: Biomea Fusion Inc., San Carlos, CA
– sequence: 13
  givenname: Thomas
  surname: Butler
  fullname: Butler, Thomas
  organization: Biomea Fusion Inc., San Carlos, CA
BookMark eNp9kM1OAjEUhRujiYA-gLu-QPW288NUVwMRIYFgIq4nnWkr1dKaThnDA_je8qNbV3dzvpNzvz46d94phG4o3FJasLvaei8JA8YIHUKaZmeoRzNWEAAG56gHADlJ-ZBeon7bvgPQNGFZD32PNppkAPe4dHgZhLU7PDJedMJYUVuFx74TVrmIZ25tahN9wF7jyXyV4C8T13hq3tb4RVnVRNOZuMPCSfzs4wEpXTRWbT_UxjS4_AsYd8TJYhtFVBKXi_kVutDCtur69w7Q6-RxNZ6S-fJpNi7npKFFlpE0yXktcl0wqiXXkhU8rTnPM56nWlIYipw3CiTkQhZpXmQ8oZKBTLRIEqpYMkD01NsE37ZB6eozmI0Iu4pCdfBYHT1WB4_VyeOeeTgxaj-sMypUbWOUa5Q0Yf90Jb35h_4BY197tQ
CitedBy_id crossref_primary_10_1007_s12185_023_03681_0
ContentType Journal Article
Copyright 2022 The American Society of Hematology
Copyright_xml – notice: 2022 The American Society of Hematology
DBID AAYXX
CITATION
DOI 10.1182/blood-2022-170445
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 6192
ExternalDocumentID 10_1182_blood_2022_170445
S0006497122043105
GroupedDBID ---
-~X
.55
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6J9
AAEDW
AAXUO
ABOCM
ABVKL
ACGFO
ADBBV
AENEX
AFOSN
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
K-O
KQ8
L7B
LSO
MJL
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
0R~
0SF
AALRI
AAYXX
ADVLN
AFETI
AITUG
AKRWK
CITATION
H13
ID FETCH-LOGICAL-c1855-4369ba6f821fd9fd2894b9965964fd107a69ce0d06ad84685931d20d3fa331e23
IEDL.DBID ABVKL
ISSN 0006-4971
IngestDate Thu Sep 12 16:42:25 EDT 2024
Fri Feb 23 02:37:06 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1855-4369ba6f821fd9fd2894b9965964fd107a69ce0d06ad84685931d20d3fa331e23
OpenAccessLink https://doi.org/10.1182/blood-2022-170445
PageCount 2
ParticipantIDs crossref_primary_10_1182_blood_2022_170445
elsevier_sciencedirect_doi_10_1182_blood_2022_170445
PublicationCentury 2000
PublicationDate 2022-11-15
PublicationDateYYYYMMDD 2022-11-15
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-15
  day: 15
PublicationDecade 2020
PublicationTitle Blood
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0014325
Score 2.4439995
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 6191
Title Bmf-500: An Orally Bioavailable Covalent Inhibitor of FLT3 with High Selectivity and Potent Antileukemic Activity in FLT3-Mutated AML
URI https://dx.doi.org/10.1182/blood-2022-170445
Volume 140
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9RAEC6WWXxcRGcV18dSB_EghOlH0pl4ywwOu-6MCu7K3kIn3cHgbM8yzAj7A_zfVuUhCnrxFkIKQld11fd11wPgVeqE5RkWREukieKKeIrNDCfYiFoqw8eQXJy8-mBOL-P3V8nVAcyHWhhOq-x9f-fTW2_dv5n0qzm5aRqu8aVwmqVScXmn5D6mhyo1Qo3gMJ99OV_-ukyIteoGGRB5ZoH-cpOQ9aTLDlec0i5TEXNR09_C028hZ_EQHvRYEfPudx7BgQ9jOMoD8eTrW3yNbfZmeyw-hjuz4enefJjhNoa7q_7q_Ah-zK7rKBHiLeYBP27ten2LJGO_22bN5VM435DRUQjCs_C1KWmjb3FT42J5oZEPa5EzQvBzOzanHTiBNjj8tNmxSB525F323zjTHvPhgya04tFqz4jWYb5aPobLxbuL-WnUz2CIKorkSRRrk5XW1FMla5fVjvhZXGbchdDEtSPuaE1WeeGEsY6gDHdPk04Jp2urtfRKP4FR2AT_FFCWlShtorOKMJhVZekJenpdJVVmUz_1x_BmWPripmu1UbQUZaqKVk8F66no9HQM8aCc4g97KSgU_Fvs2f-JPYf7nY3ISCYvYLTb7v1LAiO78qQ3thOC42fnPwHXQtpd
link.rule.ids 315,786,790,27602,27957,27958,45698
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6CQ5tcSuu0NOlrDqWHgrB2V1p7e5NNjNNIaaFOyU2stCsq4qyDsQP5Af3fndGjtJBeehNCA2Jndub7dufB2PuxDQ3NsEBawlUQlchTjFaUYBNWXCg6hqTi5OxCLS6jz1fx1R6b9bUwlFbZ-f7Wpzfeunsz6lZzdFvXVOOL4VSPuaDyTk59TPcRDejJgO0n0-_n6e_LhEiKdpABkmcS6C43EVmP2uxwQSntfBxGVNT0UHj6I-TMn7InHVaEpP2dZ2zP-SE7Sjzy5Jt7-ABN9mZzLD5kj6b908Gsn-E2ZI-z7ur8iP2c3lRBHIafIPHwZWNWq3tAGXNn6hWVT8FsjUaHIQjO_I-6wI2-gXUF83QpgQ5rgTJC4FszNqcZOAHGW_i63pJI4rfoXXbXlGkPSf9B7RvxINsRorWQZOlzdjk_Xc4WQTeDISgxksdBJJUujKomgldWVxb5WVRo6kKoosoidzRKly60oTIWoQx1T-NWhFZWRkruhHzBBn7t3UsGvCjDwsRSl4jBjCgKh9DTyTIutRm7iTtmH_ulz2_bVht5Q1EmIm_0lJOe8lZPxyzqlZP_ZS85hoJ_i538n9g7drBYZmmenl2cv2KHrb3wgMev2WC72bk3CEy2xdvO8H4BMurcXQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bmf-500%3A+An+Orally+Bioavailable+Covalent+Inhibitor+of+FLT3+with+High+Selectivity+and+Potent+Antileukemic+Activity+in+FLT3-Mutated+AML&rft.jtitle=Blood&rft.au=Law%2C+Brian&rft.au=Rughwani%2C+Tripta&rft.au=Archer%2C+Tenley+C.&rft.au=Kumar%2C+Lekha&rft.date=2022-11-15&rft.pub=Elsevier+Inc&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=140&rft.spage=6191&rft.epage=6192&rft_id=info:doi/10.1182%2Fblood-2022-170445&rft.externalDocID=S0006497122043105
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon